The global psoriasis market size was valued at USD 28.5 billion in 2023. It is expected to grow at a CAGR of 9.20% during the forecast period of 2024-2032, driven by the growing prevalence of psoriasis cases. The market is experiencing robust growth and is expected to reach USD 63.2 billion by 2032.
This product will be delivered within 5-7 business days.
Global Psoriasis Market Analysis
Psoriasis is a chronic, non-communicable skin disorder characterised by red patches and flaky scales, affecting millions globally and contributing significantly to the global burden of dermatological diseases. The psoriasis market is primarily driven by the increasing prevalence of the disease and the growing awareness of its impact on quality of life.Market Drivers
- Increasing Disease Prevalence: The global increase in psoriasis cases has been a primary driver for the market. Factors such as genetic predisposition combined with environmental factors like stress and smoking contribute to the rising incidence of the disease.
- Advancements in Treatment Options: There has been significant progress in the development of biologics and novel therapeutics, which offer improved efficacy and safety profiles over traditional systemic therapies. This has encouraged more patients to seek treatment, thereby expanding the market.
- Awareness and Education: Increased awareness about psoriasis and its management, driven by patient advocacy groups and governmental initiatives, has led to earlier diagnosis and treatment adoption, further propelling market growth.
- Healthcare Expenditure: Enhanced healthcare infrastructure and increased spending on chronic diseases in developed and developing countries alike support the psoriasis treatment market by making treatments more accessible to a larger population.
Market Challenges
- High Cost of Treatment: The high cost associated with advanced biologics and novel treatment modalities remains a significant barrier. These costs often place a substantial burden on healthcare systems and can be prohibitive for patients without adequate insurance coverage.
- Market Saturation and Competition: The psoriasis treatment market is becoming increasingly competitive with many similar biologics and biosimilars. This competition, while beneficial in reducing drug costs, can also lead to market saturation, limiting the growth of individual market players.
- Adverse Side Effects: Despite the effectiveness of newer treatments, the potential for severe side effects and the requirement for long-term management of the disease can deter patients from continuing with or initiating therapy.
- Regulatory Hurdles: Stringent regulatory requirements for the approval of new treatments can delay market entry for innovative drugs, posing a challenge for pharmaceutical companies in the psoriasis sector.
Future Opportunities
- Personalised Medicine: As research progresses, there is a growing opportunity for the development of personalised treatment approaches tailored to individual genetic profiles and disease manifestations. This could enhance treatment efficacy and reduce side effects.
- Emerging Markets: Expanding into emerging markets where there is growing healthcare infrastructure and increased healthcare spending represents a significant opportunity for growth. These regions may have untapped patient populations who are just beginning to access advanced treatments.
- Integrated Healthcare Solutions: Offering comprehensive solutions that combine medication with supportive care and patient education could differentiate offerings in a crowded market, adding value and improving patient outcomes.
- Innovation in Drug Delivery Systems: Developing innovative delivery systems such as topical treatments with higher efficacy and lower systemic side effects could meet unfulfilled needs in the market, offering convenience and improving patient compliance.
Global Psoriasis Market Trends
The psoriasis treatment market is evolving, influenced by a variety of clinical, technological, and socio-economic trends. These developments are shaping the strategies of pharmaceutical companies, healthcare providers, and policymakers. Here are key trends impacting this sector:- Shift Towards Biologics and Novel Therapeutics
- Rise of Biosimilars
- Increasing Personalisation of Treatment
- Integration of Digital Tools and Telehealth
- Focus on Patient-Centric Care Models
- Regulatory and Reimbursement Landscape Adjustments
- Expansion in Emerging Markets
Global Psoriasis Market Segmentation
Market Breakup by Drug Class
- Interleukins Inhibitors
- TNF Inhibitors
- PDE4 Inhibitors
- Vitamin D Analogs
- Others
Market Breakup by Types
- Psoriatic Arthritis
- Plaque Psoriasis
- Others
Market Breakup by Treatment Types
- Biologic Drugs
- Small Molecule Systemic Drugs
- Tropical Therapies
Market Breakup by Route of Administration
- Parenteral
- Topical
- Oral
- Others
Market Breakup by Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Psoriasis Market Competitive Landscape
The competitive landscape of the global psoriasis treatment market is characterised by intense competition among numerous major players. Key players include AbbVie Inc., Amgen Inc., AstraZeneca, Biogen Idec, Boehringer Ingelheim, Dr. Reddy’s Laboratories, Eli Lilly and Company, Johnson and Johnson, Leo Pharma AS, Merck and Co. Inc., Novartis AG, Pfizer Inc., Stiefel Laboratories Inc., Sun Pharmaceutical Industries Limited, and Valeant Pharmaceuticals. These companies are actively engaged in various strategic activities to strengthen their market positions. Common market activities include mergers and acquisitions, aimed at expanding product portfolios and geographic reach; robust research and development initiatives to innovate and introduce new treatment options; and strategic partnerships and collaborations to leverage mutual capabilities in drug development and marketing. These efforts are central to maintaining competitive advantage and responding to the evolving needs of the psoriasis treatment marketplace.Key Questions Answered in the Report
- What is the current and future performance of the psoriasis market?
- What are the main challenges facing the psoriasis market?
- What are the key drivers of the psoriasis market?
- What emerging trends are shaping the future of the psoriasis market?
- How is precision medicine transforming treatment approaches in the psoriasis market?
- How is patient-centered care enhancing treatment outcomes for psoriasis patients?
- What factors are driving the substantial growth of interleukin inhibitors in the psoriasis market?
- Why does plaque psoriasis dominate the psoriasis treatment market demand?
- Why are retail pharmacies critical in the distribution of psoriasis treatments?
- What are the common strategies used by key players in the psoriasis market?
Key Benefits for Stakeholders
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global psoriasis market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the psoriasis market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the psoriasis industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
This product will be delivered within 5-7 business days.
Table of Contents
1 Preface
3 Psoriasis Disease Overview
4 Patient Profile
5 Psoriasis Epidemiology Analysis
6 Global Psoriasis Treatment Market Overview
7 Global Psoriasis Treatment Market Landscape
8 Psoriasis Treatment Challenges and Unmet Needs
10 Global Psoriasis Treatment Market Dynamics
11 Global Psoriasis Treatment Market Segmentation
12 North America Psoriasis Treatment Market
13 Europe Psoriasis Treatment Market
14 Asia Pacific Psoriasis Treatment Market
15 Latin America Psoriasis Treatment Market
16 Middle East and Africa Psoriasis Treatment Market
17 Regulatory Framework
18 Patent Analysis
19 Grants Analysis
20 Clinical Trials Analysis
21 Funding and Investment Analysis
22 Partnership and Collaborations Analysis
23 Supplier Landscape
24 Psoriasis Treatment Market- Distribution Model (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
27 Payment Methods (Additional Insight)
Companies Mentioned
- Pfizer Inc.
- Abbvie Inc.
- Novartis AG
- Amgen Inc.
- Boehringer Ingelheim International Gmbh.
- Merck & Co Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Astrazeneca
- Ampio Pharmaceuticals Inc.
- Eli Lilly and Company
- Novartis International AG
- Sun Pharmaceuticals Industries Ltd.
- Stiefel Laboratories
- Ucb S.A.
- Leo Pharma
- Cipla Inc.
- Rowan Bioceuticals
- Glenmark Pharmaceuticals
- Win-Medicare Pvt. Ltd.
- Sanofi S.A.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | July 2024 |
Forecast Period | 2024 - 2032 |
Estimated Market Value ( USD | $ 31.2 Billion |
Forecasted Market Value ( USD | $ 63.2 Billion |
Compound Annual Growth Rate | 9.2% |
Regions Covered | Global |
No. of Companies Mentioned | 21 |